Abstract
In view of the current COVID-19 pandemic, the development of vaccination strategies against SARS-CoV-2 is a priority. Considering that risk groups are a priority, it is essential to develop vaccination strategies that have an adequate safety profile. In this context, subunits vaccines have been shown to be a promising alternative because they are safer, although they are often less immuno…